Human antibodies to human CD20 and method of using thereof

Details for Australian Patent Application No. 2008282152 (hide)

Owner Regeneron Pharmaceuticals, Inc.

Inventors Allison, Erin M.; Wang, Li-Hsien; Stevens, Sean; Martin, Joel H.

Agent Watermark

Pub. Number AU-A-2008282152

PCT Pub. Number WO2009/018411

Priority 61/067,994 03.03.08 US; 60/962,811 31.07.07 US

Filing date 31 July 2008

Wipo publication date 5 February 2009

International Classifications

C07K 16/28 (2006.01) Immunoglobulins, e.g. monoclonal or polyclonal antibodies

A61K 39/395 (2006.01) Medicinal preparations containing antigens or antibodies - Antibodies

A61P 35/00 (2006.01) Antineoplastic agents

Event Publications

25 February 2010 PCT application entered the National Phase

  PCT publication WO2009/018411 Priority application(s): WO2009/018411

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2008282156-Process for preparing 5-fluoro-1H-pyrazolo [3, 4-b] pyridin3-amine and derivatives thereof

2008282150-Improved surgical instruments